| Literature DB >> 32699606 |
Hui Ma1, Ya-Nan Li1, Lin Song1, Rui Liu1, Xiaolei Li1, Qianwen Shang1, Ying Wang2, Changshun Shao3, Yufang Shi1.
Abstract
BACKGROUND: Mesenchymal stem/stromal cells (MSCs) and macrophages are critical components in many tissue microenvironments, including that in adipose tissue. The close interaction between MSCs and macrophages modulates various adipose-related disease development. However, the effects of macrophages on the fate of MSCs remain largely elusive. We here studied the effect of macrophages on the adipogenic differentiation of MSCs.Entities:
Keywords: Adipogenesis; Inflammation cytokines; Macrophages; hADSCs
Year: 2020 PMID: 32699606 PMCID: PMC7372775 DOI: 10.1186/s13578-020-00450-y
Source DB: PubMed Journal: Cell Biosci ISSN: 2045-3701 Impact factor: 7.133
Fig. 1Macrophage-derived supernatants inhibit adipocyte differentiation of hADSCs. a Scheme of the experimental procedure. hADSCs (2 × 104) were plated and cultured with adipogenesis-inducing medium (AD) with or without the supernatants from different macrophage subtypes at the ratio of 1:1 in 48-well plate, medium was changed every 3 days. b hADSCs cells that were induced to undergo adipogenic differentiation were fixed for triglycerides staining with Oil Red O to show lipid droplets. c Western blot analysis of the protein levels of PPAR-γ in hADSCs cultured in different conditions for 5 days. d Expression of adipogenic genes were measured by Q-PCR assay on day 3. e hADSCs were pre-treated with the specific supernatant for 24 h, then changed to adipogenic inducing medium without supernatant, lipid droplets in hADSCs were revealed by Oil Red O staining after 9 days. Scale bars are 100 μm
Fig. 2The adipogenesis-inhibiting effect of macrophage supernatants is dependent on secretory macromolecule. a hADSCs were cultured with adipogenesis-inducing medium (AD) with or without the supernatant from different macrophage subtypes (> 3 kDa or < 3 kDa) at the ratio of 1:1 in 48 plate, medium was changed every 3 days. After being cultured for 9 days, cells were fixed for triglycerides staining with Oil Red O to show lipid droplets. b Expression of adipogenesis-related genes in hADSCs treated with macrophages-derived supernatant (> 3 kDa) was measured by Q-PCR on day 3. c Western blot analysis of the protein levels of PPAR-γ in hADSCs cultured with different condition medium. All scale bars, 100 μm
Fig. 3TNF-α and IL-1β repress the adipogenesis of hADSCs. a hADSCs were cultured with adipogenesis-inducing medium (AD) with or without IL-6, IL-12, TNF-α and IL-1β (5 ng/mL each), respectively. Medium was changed every 3 days. After being cultured for 9 days, cells were fixed for triglycerides staining with Oil Red O. b Expression of adipogenesis-related genes in hADSCs treated with TNF-α/IL-1β (0.1 ng/mL each) was determined by Q-PCR assay on day 3. c Western blot analysis of PPAR-γ in adipogenic hADSCs interfered with TNF-α or IL-1β cytokines at different concentration. Scale bars, 100 μm
Fig. 4Macrophages restrict adipogenic differentiation of hADSCs through TNF-α and IL-1β production. a Antibody mixture (Abs) containing anti-TNF-α and anti-IL-1β (2 μg/mL each) partially relieves the inhibition of adipogenic differentiation of hADSCs by M1-sup. Cells were stained with Oil Red O after being cultured for 9 days. b Q-PCR was used to assess the expression of PPAR-γ, C/EBP-γ, C/EBP-α, FABP4, Glut4, LPL in hADSCs. c Western blot analysis of PPAR-γ in adipogenic hADSCs treated with TNF-α and IL-1β neutralizing antibodies in combination. Scale bars, 100 μm
Fig. 5A schematic diagram depicting the inhibitory effects of macrophages on adipocyte differentiation of hADSCs. M0, M1 and M2 macrophages can all inhibit adipogenic differentiation of hADSCs. M1 macrophage exert inhibitory effects by secreting inflammatory cytokines TNF-α and IL-1β
List of primers used for quantitative polymerase chain reaction (β-actin was used as an internal control)
| Gene | Primer sequences |
|---|---|
| PPAR-γ | |
| Forward | 5′-TACTGTCGGTTTCAGAAATGCC-3′ |
| Reverse | 5′-GTCAGCGGACTCTGGATTCAG-3′ |
| C/EBP-α | |
| Forward | 5′-CGAAGAGACGGCCCTTGCTG-3′ |
| Reverse | 5′-GGGATACATCCTCAGGGCCACA-3′ |
| C/EBP-β | |
| Forward | 5′-CTTCAGCCCGTACCTGGAG-3′ |
| Reverse | 5′-GGAGAGGAAGTCGTGGTGC-3′ |
| C/EBP-γ | |
| Forward | 5′-ACTCCAGGGGTGAACGGAAT-3′ |
| Reverse | 5′-CATGGGCGAACTCTTTTTGCT-3′ |
| Glut4 | |
| Forward | 5′-TGGGCGGCATGATTTCCTC-3′ |
| Reverse | 5′-GCCAGGACATTGTTGACCAG-3′ |
| LPL | |
| Forward | 5′-TCATTCCCGGAGTAGCAGAGT-3′ |
| Reverse | 5′-GGCCACAAGTTTTGGCACC-3′ |
| FABP4 | |
| Forward | 5′-ACTGGGCCAGGAATTTGACG-3′ |
| Reverse | 5′-CTCGTGGAAGTGACGCCTT-3′ |
| IL-6 | |
| Forward | 5′-CAGCCCTGAGAAAGGAGACATG-3′ |
| Reverse | 5′-GGTTGTTTTCTGCCAGTGCCT-3′ |
| IL-12 | |
| Forward | 5′-GATGGCCCTGTGCCTTAGTA-3′ |
| Reverse | 5′-TCAAGGGAGGATTTTTGTGG-3′ |
| IL-1β | |
| Forward | 5′-GACCTGAGCACCTTCTTTCCCT-3′ |
| Reverse | 5′-CATCGTGCACATAAGCCTCGT-3′ |
| TNF-α | |
| Forward | 5′-GACAAGCCTGTAGCCCATGTTG-3′ |
| Reverse | 5′-TGGTTATCTCTCAGCTCCACGC-3′ |
| TGM2 | |
| Forward | 5′-CAAGGCCCGTTTTCCACTAAG-3′ |
| Reverse | 5′-GAGGCGATACAGGCCGATG-3′ |
| CCL22 | |
| Forward | 5′-ATCGCCTACAGACTGCACTC-3′ |
| Reverse | 5′-GACGGTAACGGACGTAATCAC-3′ |
| β-actin | |
| Forward | 5′-TTGCCGACAGGATGCAGAAGGA-3′ |
| Reverse | 5′-AGGTGGACAGCGAGGCCAGGAT-3′ |